Back

BELL

-9.37%
NEUTRAL

Belluscura Announces Proposed Equity Fundraising

Why we think this is neutral

The proposed equity fundraising by Belluscura plc raises several concerns, including a significant 69.2% discount to the current share price, the conditional nature of a large portion of the fundraising subject to shareholder approval, and the lack of detailed financial information. These negative factors outweigh the positive signal of director participation, resulting in a neutral sentiment score.

Key Points

  • Proposed equity fundraising to raise a minimum of £3.8 million
  • Issue price of 2 pence per share represents a 69.2% discount to the current share price
  • Fundraising to be conducted in two tranches - a firm placing and a conditional placing
  • Conditional placing subject to shareholder approval
  • Net proceeds to be used for product inventory, working capital, and balance sheet strength
  • Certain directors intend to participate in the placing

Summary

The medical device company announces a proposed equity fundraising, with the issue price representing a substantial discount to the current share price. The fundraising is subject to shareholder approval, raising concerns about the company's financing flexibility.

Belluscura plc has announced a proposed equity fundraising to raise a minimum of approximately £3.8 million (approximately $4.8 million) through a placing of new ordinary shares. The fundraising will be conducted in two tranches - a firm placing of 33,000,000 shares and a conditional placing of a minimum of 159,000,000 shares, both at an issue price of 2 pence per share. The net proceeds will be used to purchase product inventory, for general working capital purposes and to bolster the company's balance sheet. Certain directors have indicated an intention to participate in the placing. The issue price represents a significant discount of 69.2% to the closing mid-market price of 6.5 pence per share on the last practicable date prior to the announcement. The conditional placing is subject to shareholder approval at a general meeting.

Key Dates

11 February 2025
General
First Admission of Firm Placing Shares
Impact Score: 6
04 March 2025
General
Second Admission of Conditional Placing Shares
Impact Score: 6
28 February 2025
General Meeting
General Meeting to approve Resolutions
Impact Score: 7
PLACING